Peer-reviewed translational research paves the way for first-in-class autotaxin inhibitor IOA-289 in cancer ...Middle East

PR Newswire - News
AMSTERDAM and GENEVA, May 16, 2023 /PRNewswire/ -- iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, today announces the peer-reviewed publication of comprehensive translational research on the novel autotaxin (ATX)...

Hence then, the article about peer reviewed translational research paves the way for first in class autotaxin inhibitor ioa 289 in cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Peer-reviewed translational research paves the way for first-in-class autotaxin inhibitor IOA-289 in cancer )

Apple Storegoogle play

Last updated :

Also on site :